ASH 2014: New therapies for mantle cell lymphoma - European Medical Journal

ASH 2014: New therapies for mantle cell lymphoma

Hematology

Prof Umberto Vitolo (Città della Salute e della Scienza di Torino, Turin, Italy) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses new therapies for mantle cell lymphoma, including biologic approaches with lenalidomide plus rituximab, ibrutinib and ABT-199.

This programme has been supported by sponsorship from Celgene.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given